tellic

tellic is a life sciences data science company founded in 2015, dedicated to advancing the discovery and development of life-enhancing drugs through large language models (LLMs), natural language processing (NLP), and knowledge graph technology. Designed specifically for pharmaceutical organizations, tellic helps biomedical researchers and analysts explore and validate connections critical to drug discovery by unlocking critical relationships and insights from a complete landscape of biomedical data.

tellic's platform forms a single source of truth for biomedical concepts by extracting cause-effect features from unstructured text data — including research publications, grants, preprints, clinical trials, patents, and proprietary internal research. By dramatically increasing efficiency in searching multiple data sources and identifying relationships between biomedical entities, tellic empowers pharma companies to make breakthrough drug R&D decisions and accelerate life-enhancing therapies to patients.

Core Product: +tellic Graph

• A patented biomedical knowledge graph platform (Patent US12061870) that enables pharmaceutical organizations to generate and validate drug discovery hypotheses faster
• Compresses the time to search and accelerates the time to insight by creating a unified knowledge graph from both external and internal data sources
• Supports drug re-purposing and target prioritization, including use cases leveraging billion-edge knowledge graphs and genomically-informed subgraphs
• Provides a unified view of all relevant data that updates automatically as new research is published
• Offers a clear path for exploring concept relationships and pinpointing opportunities for drug discovery

Key Capabilities

• Biomedical NLP: Processes unstructured data with machine learning pipelines purpose-built for biomedical text, detecting biomedical concepts with PhD-level accuracy at big data scale
• Concept Search: Increases the number of relevant search results by 4X, quickly delivering insights to scientists and reducing wasted search time
• Knowledge Graph: Enables informed discovery decisions quickly and accurately with data-driven insights, surfacing relationships to inform hypothesis generation and validation
• Links biomedical concepts into preferred ontologies using machine learning, with support for ever-evolving vernacular, ontologies, and identifiers
• Delivers the most comprehensive single source of truth for each biomedical entity, derived using AI trained on thousands of PhD annotations that map all known synonyms to a single ontological concept
• Discovers the most important research through context-driven relevance

Platform Design and Customization

• Designed for pharma and customized to each organization's specific language and taxonomy
• Addresses common challenges including incomplete taxonomy of scientific concepts, fragmented and siloed document stores, and unclear understanding of biomedical concept relationships
• Goes beyond legacy NLP solutions that cannot keep pace with the expanding pace of science
• Customizable to organizational language, ontologies, and identifiers to ensure relevance and accuracy

Company Background and Team

• Founded in 2015 by Richard Wendell, a Fortune 500 Chief Data Officer, with a vision to make it easy for pharma companies to apply emerging data science technologies
• Pioneers a new category of enterprise-scale biomedical language processing and knowledge discovery powered by machine learning
• Innovation emerges from three distinct skill sets: life science, data science, and DevOps
• Team includes thought leaders with expertise in molecular biology, functional genomics, drug discovery, AI and machine learning, linguistics, image processing, big data engineering, and enterprise software development
• Cross-disciplinary training approach elevates the group and expands the frontier of pharma technologies

Guided by core values that include elevating the group, expanding the frontier, using data to make decisions, and relentlessly pursuing excellence, tellic is committed to delivering novel insights that can accelerate life-enhancing drugs to the patients who need them most.